Vinblastine Secretion by Intestinal Cancer Cells
Author Information
Author(s): J. Hunter, B.H. Hirst, N.L. Simmons
Primary Institution: University of Newcastle upon Tyne
Hypothesis
The expression of P-glycoprotein is associated with transepithelial secretion of MDR-substrates such as vinblastine in epithelial tumor cells from the gastrointestinal tract.
Conclusion
The study provides direct evidence that P-glycoprotein in intestinal adenocarcinoma cells promotes detoxification through the secretion of vinblastine.
Supporting Evidence
- P-glycoprotein was detected in both HCT-8 and T84 cell lines.
- Vinblastine secretion was significantly inhibited by verapamil.
- Cellular vinblastine accumulation was greater from the basal side compared to the apical side.
Takeaway
This study shows that certain cancer cells can push out a drug called vinblastine, which helps them resist treatment, and this process is linked to a special protein they have.
Methodology
The study involved culturing two human adenocarcinoma cell lines (HCT-8 and T84) and measuring their ability to secrete vinblastine across epithelial layers.
Limitations
The study does not explore the long-term effects of vinblastine secretion in vivo or the impact of other potential confounding factors.
Participant Demographics
Human intestinal adenocarcinoma cell lines (HCT-8 and T84).
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website